详情页 - 广东省中医院知识库

当前位置：首页 > 详情页

Inhibitory effects of Rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activity (vol 12, 645140, 2021)

10| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Zhuhai, Peoples R China [2]Univ Western Australia, Sch Biomed Sci, Perth, WA, Australia [3]Guangxi Med Univ, Peoples Hosp Nanning 1, Dept Orthoped, Affiliated Hosp 5, Nanning, Peoples R China [4]Guangzhou Univ Chinese Med, Affiliated Hosp 5, Guangzhou, Peoples R China [5]Jinan Univ, Formula Pattern Res Ctr, Sch Tradit Chinese Med, Guangzhou, Peoples R China

出处：

DOI：

ISSN：

关键词： osteoclast NFATc1 ROS rhaponticin bone

语种：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2022]版：

大类 | 2 区

医学

小类 | 2 区药学

最新[2025]版：

大类 | 3 区医学

小类 | 3 区药学

JCR分区：

出版当年[2021]版：

Q1 PHARMACOLOGY & PHARMACY

最新[2023]版：

Q1 PHARMACOLOGY & PHARMACY

影响因子： 4.4 最新[2023版] 5 最新五年平均 5.988 出版当年[2021版] 6.455 出版当年五年平均 5.811 出版前一年[2020版] 5.6 出版后一年[2022版]

第一作者：

第一作者机构： [1]Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Zhuhai, Peoples R China [2]Univ Western Australia, Sch Biomed Sci, Perth, WA, Australia

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS Activity [2]Dendrobine attenuates osteoclast differentiation through modulating ROS/NFATc1/MMP9 pathway and prevents inflammatory bone destruction [3]Cycloastragenol Attenuates Osteoclastogenesis and Bone Loss by Targeting RANKL-Induced Nrf2/Keap1/ARE, NF-κB, Calcium, and NFATc1 Pathways. [4]Dendrobine attenuates osteoclast differentiation through modulating ROS/NFATc1/ MMP9 pathway and prevents inflammatory bone destruction. [5]A novel Glycyrrhiza glabra extract liquiritin targeting NFATc1 activity and ROS levels to counteract ovariectomy-induced osteoporosis and bone loss in murine model [6]A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species. [7]Fangchinoline protects against bone loss in OVX mice via inhibiting osteoclast formation, bone resorption and RANKL-induced signaling. [8]Asiatic Acid Inhibits OVX-Induced Osteoporosis and Osteoclastogenesis Via Regulating RANKL-Mediated NF-κb and Nfatc1 Signaling Pathways. [9]Aconine inhibits RANKL-induced osteoclast differentiation in RAW2647 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression [10]Artesunate suppresses RANKL-induced osteoclastogenesis through inhibition of PLCγ1-Ca2+-NFATc1 signaling pathway and prevents ovariectomy-induced bone loss